clinician ethically agree perform test not return incidental secondary findings patient understands results mean not want secondary findings results not primary target test sought clinician option declining perform test referring patient commission advises white house calls better communication incidental findings secondary findings clinicians researchers companies consider findings crop course testing devise better plans relay possibility patients explanations will not given commission calls research funds stay incidental findings arise potential costs benefits harms commission report comes time fda grappling concerns ensuring reliability home genetics testing regulators come grips results probe highly predictive cancer alzheimer disease conveyed patients genetic counseling coincides recommendations